首页> 美国卫生研究院文献>Epidemiology and Infection >Characteristics of hospitalised patients with influenza in 2015–2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1
【2h】

Characteristics of hospitalised patients with influenza in 2015–2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1

机译:以色列北部2015-2016年住院流感患者的特征:三种传播株和对2009 A / H1N1的持续恐惧

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to characterise children and adults diagnosed with influenza who were admitted to three medical centres in northern Israel in the winter of 2015–2016, a unique season due to infection with three types of influenza strains: A/H1N1, Aon-H1N1 and B. Data were collected retrospectively from medical records. Influenza A/H1N1 infected mainly adults (61% vs. 16% in children, P < 0.001) while influenza B was the common type in children (54% vs. 28% in adults, P < 0.001). Adults (36% vs. 5% in children, P < 0.001) and patients infected with A/H1N1 had higher rates of pneumonia (34% vs. 16% and 14% in influenza B and Aon-H1N1, respectively, P = 0.002). Treatment with oseltamivir was prescribed to 90% of patients; adults had higher rates of treatment (96% vs. 84% in children, P = 0.002) as well as patients infected with A/H1N1 (96% vs. 86% in influenza B and Aon-H1N1, respectively, P = 0.04). Oseltamivir was given after a mean of 3.6 days of symptoms. Preferential infection of adults by A/H1N1 was evident in Israel in 2015–2016; pneumonia rates were higher in adults and in A/H1N1-infected patients. Oseltamivir was prescribed to most patients but especially to those infected with A/H1N1, and was given relatively late in the course of the disease.
机译:这项研究旨在描述2015年至2016年冬天在以色列北部三个医疗中心收治的确诊为流感的儿童和成人,这是由于感染三种类型的流感病毒株而造成的独特季节:A / H1N1,A /非H1N1和B。数据是从医疗记录中回顾性收集的。甲型/ H1N1流感主要感染成人(儿童占61%,儿童占16%,P <0.001),而儿童乙型流感是常见类型(成人占54%,对28%,P <0.001)。成人(36%比儿童的5%,P <0.001)和感染A / H1N1的患者的肺炎发生率更高(分别为B,A和非H1N1流感的34%和16%和14%) = 0.002)。 90%的患者处方了奥司他韦治疗;成人的治疗率较高(儿童为96%,儿童为84%,P = 0.002),以及感染A / H1N1的患者(分别为B型和A /非H1N1流感患者,分别为96%和86%,P = 0.04)。在平均3.6天出现症状后给予Oseltamivir。 2015-2016年,以色列明显受到A / H1N1病毒的成人感染;成人和A / H1N1感染患者的肺炎发生率更高。 Oseltamivir是大多数患者的处方药,特别是A / H1N1感染的患者,并且在病程较晚才服用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号